Tria Gen Wealth Management LLC Bristol Myers Squibb CO Transaction History

Tria Gen Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $289 - $323	-5 Reduced 0.13%	3,820 $221,000
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $3,041 - $1.8 Million	-23,393 Reduced 85.95%	3,825 $272,000
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $21,931 - $24,153	-302 Reduced 1.1%	27,218 $2.1 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $1.45 Million - $1.74 Million	23,545 Added 592.33%	27,520 $2.01 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $213,179 - $248,517	3,975 New	3,975 $248,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $274,607 - $321,667	-4,641 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $216,127 - $235,363	-3,491 Reduced 42.93%	4,641 $315,000
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $469,541 - $532,076	8,132 New	8,132 $504,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tria Gen Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tria Gen Wealth Management LLC with notifications on news.